nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinine—SLCO1A2—Prednisolone—ankylosing spondylitis	0.0978	0.115	CbGbCtD
Quinine—SLCO1A2—Prednisone—ankylosing spondylitis	0.0924	0.108	CbGbCtD
Quinine—SLCO1A2—Dexamethasone—ankylosing spondylitis	0.0577	0.0677	CbGbCtD
Quinine—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.048	0.0563	CbGbCtD
Quinine—SLCO1A2—Methotrexate—ankylosing spondylitis	0.0464	0.0544	CbGbCtD
Quinine—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0412	0.0484	CbGbCtD
Quinine—CYP1A1—Dexamethasone—ankylosing spondylitis	0.0399	0.0468	CbGbCtD
Quinine—CYP3A7—Dexamethasone—ankylosing spondylitis	0.0319	0.0375	CbGbCtD
Quinine—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.0319	0.0375	CbGbCtD
Quinine—CYP2C19—Prednisone—ankylosing spondylitis	0.031	0.0363	CbGbCtD
Quinine—CYP2E1—Dexamethasone—ankylosing spondylitis	0.0308	0.0362	CbGbCtD
Quinine—ABCB1—Betamethasone—ankylosing spondylitis	0.0268	0.0315	CbGbCtD
Quinine—ABCB1—Prednisolone—ankylosing spondylitis	0.0264	0.031	CbGbCtD
Quinine—ABCB1—Prednisone—ankylosing spondylitis	0.025	0.0293	CbGbCtD
Quinine—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0247	0.029	CbGbCtD
Quinine—CYP3A5—Dexamethasone—ankylosing spondylitis	0.024	0.0281	CbGbCtD
Quinine—CYP2C8—Dexamethasone—ankylosing spondylitis	0.023	0.027	CbGbCtD
Quinine—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0193	0.0227	CbGbCtD
Quinine—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0187	0.022	CbGbCtD
Quinine—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0161	0.0189	CbGbCtD
Quinine—CYP3A4—Betamethasone—ankylosing spondylitis	0.0161	0.0188	CbGbCtD
Quinine—CYP3A4—Prednisolone—ankylosing spondylitis	0.0158	0.0186	CbGbCtD
Quinine—ABCB1—Dexamethasone—ankylosing spondylitis	0.0156	0.0183	CbGbCtD
Quinine—CYP3A4—Prednisone—ankylosing spondylitis	0.015	0.0176	CbGbCtD
Quinine—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0147	0.0172	CbGbCtD
Quinine—ABCB1—Methotrexate—ankylosing spondylitis	0.0125	0.0147	CbGbCtD
Quinine—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00934	0.011	CbGbCtD
Quinine—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.000373	0.00252	CcSEcCtD
Quinine—Haemorrhage—Betamethasone—ankylosing spondylitis	0.000373	0.00252	CcSEcCtD
Quinine—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.000371	0.00251	CcSEcCtD
Quinine—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.00037	0.0025	CcSEcCtD
Quinine—Ataxia—Methotrexate—ankylosing spondylitis	0.000369	0.0025	CcSEcCtD
Quinine—Vision blurred—Prednisolone—ankylosing spondylitis	0.000367	0.00248	CcSEcCtD
Quinine—Liver function test abnormal—Methotrexate—ankylosing spondylitis	0.000362	0.00245	CcSEcCtD
Quinine—Visual impairment—Dexamethasone—ankylosing spondylitis	0.00036	0.00243	CcSEcCtD
Quinine—Visual impairment—Betamethasone—ankylosing spondylitis	0.00036	0.00243	CcSEcCtD
Quinine—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.00036	0.00243	CcSEcCtD
Quinine—Erythema—Triamcinolone—ankylosing spondylitis	0.000358	0.00242	CcSEcCtD
Quinine—Erythema—Methylprednisolone—ankylosing spondylitis	0.000357	0.00242	CcSEcCtD
Quinine—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.000357	0.00242	CcSEcCtD
Quinine—Angioedema—Prednisolone—ankylosing spondylitis	0.000356	0.00241	CcSEcCtD
Quinine—Breast disorder—Methotrexate—ankylosing spondylitis	0.000355	0.0024	CcSEcCtD
Quinine—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	0.000354	0.00239	CcSEcCtD
Quinine—Vertigo—Prednisolone—ankylosing spondylitis	0.00035	0.00236	CcSEcCtD
Quinine—Syncope—Prednisolone—ankylosing spondylitis	0.000349	0.00236	CcSEcCtD
Quinine—Eye disorder—Dexamethasone—ankylosing spondylitis	0.000349	0.00236	CcSEcCtD
Quinine—Eye disorder—Betamethasone—ankylosing spondylitis	0.000349	0.00236	CcSEcCtD
Quinine—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.000342	0.00231	CcSEcCtD
Quinine—Asthma—Methotrexate—ankylosing spondylitis	0.000339	0.00229	CcSEcCtD
Quinine—Convulsion—Prednisolone—ankylosing spondylitis	0.000337	0.00228	CcSEcCtD
Quinine—Bradycardia—Prednisone—ankylosing spondylitis	0.000331	0.00224	CcSEcCtD
Quinine—Angioedema—Triamcinolone—ankylosing spondylitis	0.000327	0.00221	CcSEcCtD
Quinine—Haemoglobin—Prednisone—ankylosing spondylitis	0.000327	0.00221	CcSEcCtD
Quinine—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000326	0.00221	CcSEcCtD
Quinine—Haemorrhage—Prednisone—ankylosing spondylitis	0.000325	0.0022	CcSEcCtD
Quinine—Erythema—Dexamethasone—ankylosing spondylitis	0.000325	0.0022	CcSEcCtD
Quinine—Erythema—Betamethasone—ankylosing spondylitis	0.000325	0.0022	CcSEcCtD
Quinine—Pancytopenia—Methotrexate—ankylosing spondylitis	0.000322	0.00218	CcSEcCtD
Quinine—Vertigo—Triamcinolone—ankylosing spondylitis	0.000322	0.00217	CcSEcCtD
Quinine—Syncope—Triamcinolone—ankylosing spondylitis	0.000321	0.00217	CcSEcCtD
Quinine—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000321	0.00217	CcSEcCtD
Quinine—Syncope—Methylprednisolone—ankylosing spondylitis	0.00032	0.00217	CcSEcCtD
Quinine—Oedema—Prednisolone—ankylosing spondylitis	0.000318	0.00215	CcSEcCtD
Quinine—Neutropenia—Methotrexate—ankylosing spondylitis	0.000317	0.00215	CcSEcCtD
Quinine—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000315	0.00213	CcSEcCtD
Quinine—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.000314	0.00212	CcSEcCtD
Quinine—Shock—Prednisolone—ankylosing spondylitis	0.000313	0.00211	CcSEcCtD
Quinine—Convulsion—Triamcinolone—ankylosing spondylitis	0.00031	0.0021	CcSEcCtD
Quinine—Tachycardia—Prednisolone—ankylosing spondylitis	0.00031	0.0021	CcSEcCtD
Quinine—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.00031	0.00209	CcSEcCtD
Quinine—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00031	0.00209	CcSEcCtD
Quinine—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000307	0.00208	CcSEcCtD
Quinine—Myalgia—Triamcinolone—ankylosing spondylitis	0.000305	0.00206	CcSEcCtD
Quinine—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000304	0.00206	CcSEcCtD
Quinine—Eye disorder—Prednisone—ankylosing spondylitis	0.000304	0.00205	CcSEcCtD
Quinine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000302	0.00204	CcSEcCtD
Quinine—Flushing—Prednisone—ankylosing spondylitis	0.000302	0.00204	CcSEcCtD
Quinine—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.0003	0.00203	CcSEcCtD
Quinine—Renal failure—Methotrexate—ankylosing spondylitis	0.000297	0.00201	CcSEcCtD
Quinine—Angioedema—Betamethasone—ankylosing spondylitis	0.000297	0.00201	CcSEcCtD
Quinine—Angioedema—Dexamethasone—ankylosing spondylitis	0.000297	0.00201	CcSEcCtD
Quinine—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000294	0.00199	CcSEcCtD
Quinine—Immune system disorder—Prednisone—ankylosing spondylitis	0.000294	0.00198	CcSEcCtD
Quinine—Oedema—Triamcinolone—ankylosing spondylitis	0.000292	0.00198	CcSEcCtD
Quinine—Vertigo—Betamethasone—ankylosing spondylitis	0.000292	0.00197	CcSEcCtD
Quinine—Vertigo—Dexamethasone—ankylosing spondylitis	0.000292	0.00197	CcSEcCtD
Quinine—Syncope—Betamethasone—ankylosing spondylitis	0.000291	0.00197	CcSEcCtD
Quinine—Syncope—Dexamethasone—ankylosing spondylitis	0.000291	0.00197	CcSEcCtD
Quinine—Sweating—Methotrexate—ankylosing spondylitis	0.00029	0.00196	CcSEcCtD
Quinine—Shock—Triamcinolone—ankylosing spondylitis	0.000287	0.00194	CcSEcCtD
Quinine—Shock—Methylprednisolone—ankylosing spondylitis	0.000287	0.00194	CcSEcCtD
Quinine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000286	0.00193	CcSEcCtD
Quinine—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000286	0.00193	CcSEcCtD
Quinine—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000286	0.00193	CcSEcCtD
Quinine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000285	0.00193	CcSEcCtD
Quinine—Mental disorder—Prednisone—ankylosing spondylitis	0.000285	0.00193	CcSEcCtD
Quinine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000285	0.00192	CcSEcCtD
Quinine—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000283	0.00191	CcSEcCtD
Quinine—Malnutrition—Prednisone—ankylosing spondylitis	0.000283	0.00191	CcSEcCtD
Quinine—Erythema—Prednisone—ankylosing spondylitis	0.000283	0.00191	CcSEcCtD
Quinine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000282	0.00191	CcSEcCtD
Quinine—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000282	0.00191	CcSEcCtD
Quinine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000282	0.00191	CcSEcCtD
Quinine—Convulsion—Dexamethasone—ankylosing spondylitis	0.000281	0.0019	CcSEcCtD
Quinine—Convulsion—Betamethasone—ankylosing spondylitis	0.000281	0.0019	CcSEcCtD
Quinine—Myalgia—Dexamethasone—ankylosing spondylitis	0.000277	0.00187	CcSEcCtD
Quinine—Myalgia—Betamethasone—ankylosing spondylitis	0.000277	0.00187	CcSEcCtD
Quinine—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000273	0.00185	CcSEcCtD
Quinine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000272	0.00184	CcSEcCtD
Quinine—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000272	0.00184	CcSEcCtD
Quinine—Hepatitis—Methotrexate—ankylosing spondylitis	0.000272	0.00184	CcSEcCtD
Quinine—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000268	0.00181	CcSEcCtD
Quinine—Vision blurred—Prednisone—ankylosing spondylitis	0.000267	0.0018	CcSEcCtD
Quinine—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000266	0.0018	CcSEcCtD
Quinine—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000266	0.0018	CcSEcCtD
Quinine—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000266	0.0018	CcSEcCtD
Quinine—Oedema—Dexamethasone—ankylosing spondylitis	0.000265	0.00179	CcSEcCtD
Quinine—Oedema—Betamethasone—ankylosing spondylitis	0.000265	0.00179	CcSEcCtD
Quinine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000262	0.00177	CcSEcCtD
Quinine—Visual impairment—Methotrexate—ankylosing spondylitis	0.000262	0.00177	CcSEcCtD
Quinine—Shock—Dexamethasone—ankylosing spondylitis	0.000261	0.00176	CcSEcCtD
Quinine—Shock—Betamethasone—ankylosing spondylitis	0.000261	0.00176	CcSEcCtD
Quinine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000261	0.00176	CcSEcCtD
Quinine—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00026	0.00176	CcSEcCtD
Quinine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00026	0.00176	CcSEcCtD
Quinine—Agitation—Prednisone—ankylosing spondylitis	0.00026	0.00176	CcSEcCtD
Quinine—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00026	0.00176	CcSEcCtD
Quinine—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00026	0.00176	CcSEcCtD
Quinine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000259	0.00175	CcSEcCtD
Quinine—Tachycardia—Betamethasone—ankylosing spondylitis	0.000259	0.00175	CcSEcCtD
Quinine—Angioedema—Prednisone—ankylosing spondylitis	0.000259	0.00175	CcSEcCtD
Quinine—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000257	0.00174	CcSEcCtD
Quinine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000256	0.00173	CcSEcCtD
Quinine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000256	0.00173	CcSEcCtD
Quinine—Vertigo—Prednisone—ankylosing spondylitis	0.000254	0.00172	CcSEcCtD
Quinine—Eye disorder—Methotrexate—ankylosing spondylitis	0.000254	0.00172	CcSEcCtD
Quinine—Syncope—Prednisone—ankylosing spondylitis	0.000254	0.00172	CcSEcCtD
Quinine—Tinnitus—Methotrexate—ankylosing spondylitis	0.000253	0.00171	CcSEcCtD
Quinine—Anorexia—Dexamethasone—ankylosing spondylitis	0.000253	0.00171	CcSEcCtD
Quinine—Anorexia—Betamethasone—ankylosing spondylitis	0.000253	0.00171	CcSEcCtD
Quinine—Urticaria—Prednisolone—ankylosing spondylitis	0.000252	0.00171	CcSEcCtD
Quinine—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000252	0.0017	CcSEcCtD
Quinine—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000249	0.00168	CcSEcCtD
Quinine—Hypotension—Dexamethasone—ankylosing spondylitis	0.000248	0.00168	CcSEcCtD
Quinine—Hypotension—Betamethasone—ankylosing spondylitis	0.000248	0.00168	CcSEcCtD
Quinine—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000245	0.00166	CcSEcCtD
Quinine—Convulsion—Prednisone—ankylosing spondylitis	0.000245	0.00166	CcSEcCtD
Quinine—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000245	0.00166	CcSEcCtD
Quinine—Chills—Methotrexate—ankylosing spondylitis	0.000244	0.00165	CcSEcCtD
Quinine—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000242	0.00163	CcSEcCtD
Quinine—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000242	0.00163	CcSEcCtD
Quinine—Myalgia—Prednisone—ankylosing spondylitis	0.000241	0.00163	CcSEcCtD
Quinine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000241	0.00163	CcSEcCtD
Quinine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00024	0.00162	CcSEcCtD
Quinine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000239	0.00162	CcSEcCtD
Quinine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000238	0.00161	CcSEcCtD
Quinine—Mental disorder—Methotrexate—ankylosing spondylitis	0.000238	0.00161	CcSEcCtD
Quinine—Erythema—Methotrexate—ankylosing spondylitis	0.000236	0.0016	CcSEcCtD
Quinine—Malnutrition—Methotrexate—ankylosing spondylitis	0.000236	0.0016	CcSEcCtD
Quinine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000234	0.00158	CcSEcCtD
Quinine—Urticaria—Triamcinolone—ankylosing spondylitis	0.000232	0.00157	CcSEcCtD
Quinine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000232	0.00157	CcSEcCtD
Quinine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000231	0.00156	CcSEcCtD
Quinine—Oedema—Prednisone—ankylosing spondylitis	0.000231	0.00156	CcSEcCtD
Quinine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00023	0.00156	CcSEcCtD
Quinine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00023	0.00156	CcSEcCtD
Quinine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00023	0.00156	CcSEcCtD
Quinine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000229	0.00155	CcSEcCtD
Quinine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000229	0.00155	CcSEcCtD
Quinine—Shock—Prednisone—ankylosing spondylitis	0.000227	0.00154	CcSEcCtD
Quinine—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000226	0.00153	CcSEcCtD
Quinine—Tachycardia—Prednisone—ankylosing spondylitis	0.000225	0.00152	CcSEcCtD
Quinine—Skin disorder—Prednisone—ankylosing spondylitis	0.000224	0.00152	CcSEcCtD
Quinine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000223	0.00151	CcSEcCtD
Quinine—Vision blurred—Methotrexate—ankylosing spondylitis	0.000223	0.00151	CcSEcCtD
Quinine—Anorexia—Prednisone—ankylosing spondylitis	0.00022	0.00149	CcSEcCtD
Quinine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000218	0.00148	CcSEcCtD
Quinine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000218	0.00148	CcSEcCtD
Quinine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000217	0.00147	CcSEcCtD
Quinine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000217	0.00147	CcSEcCtD
Quinine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000215	0.00146	CcSEcCtD
Quinine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000215	0.00145	CcSEcCtD
Quinine—Vertigo—Methotrexate—ankylosing spondylitis	0.000212	0.00144	CcSEcCtD
Quinine—Leukopenia—Methotrexate—ankylosing spondylitis	0.000212	0.00143	CcSEcCtD
Quinine—Urticaria—Dexamethasone—ankylosing spondylitis	0.000211	0.00142	CcSEcCtD
Quinine—Urticaria—Betamethasone—ankylosing spondylitis	0.000211	0.00142	CcSEcCtD
Quinine—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00021	0.00142	CcSEcCtD
Quinine—Dizziness—Prednisolone—ankylosing spondylitis	0.00021	0.00142	CcSEcCtD
Quinine—Asthenia—Triamcinolone—ankylosing spondylitis	0.00021	0.00142	CcSEcCtD
Quinine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00021	0.00142	CcSEcCtD
Quinine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00021	0.00142	CcSEcCtD
Quinine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00021	0.00142	CcSEcCtD
Quinine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00021	0.00142	CcSEcCtD
Quinine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000209	0.00141	CcSEcCtD
Quinine—Pruritus—Triamcinolone—ankylosing spondylitis	0.000207	0.0014	CcSEcCtD
Quinine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000206	0.00139	CcSEcCtD
Quinine—Convulsion—Methotrexate—ankylosing spondylitis	0.000205	0.00139	CcSEcCtD
Quinine—Myalgia—Methotrexate—ankylosing spondylitis	0.000201	0.00136	CcSEcCtD
Quinine—Chest pain—Methotrexate—ankylosing spondylitis	0.000201	0.00136	CcSEcCtD
Quinine—Decreased appetite—Prednisone—ankylosing spondylitis	0.000201	0.00136	CcSEcCtD
Quinine—Rash—Prednisolone—ankylosing spondylitis	0.0002	0.00135	CcSEcCtD
Quinine—Dermatitis—Prednisolone—ankylosing spondylitis	0.0002	0.00135	CcSEcCtD
Quinine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.0002	0.00135	CcSEcCtD
Quinine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000199	0.00135	CcSEcCtD
Quinine—Headache—Prednisolone—ankylosing spondylitis	0.000199	0.00135	CcSEcCtD
Quinine—Confusional state—Methotrexate—ankylosing spondylitis	0.000195	0.00132	CcSEcCtD
Quinine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000193	0.00131	CcSEcCtD
Quinine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000193	0.0013	CcSEcCtD
Quinine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00019	0.00129	CcSEcCtD
Quinine—Asthenia—Dexamethasone—ankylosing spondylitis	0.00019	0.00129	CcSEcCtD
Quinine—Asthenia—Betamethasone—ankylosing spondylitis	0.00019	0.00129	CcSEcCtD
Quinine—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000189	0.00128	CcSEcCtD
Quinine—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000189	0.00128	CcSEcCtD
Quinine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000189	0.00128	CcSEcCtD
Quinine—Nausea—Prednisolone—ankylosing spondylitis	0.000189	0.00128	CcSEcCtD
Quinine—Pruritus—Dexamethasone—ankylosing spondylitis	0.000188	0.00127	CcSEcCtD
Quinine—Pruritus—Betamethasone—ankylosing spondylitis	0.000188	0.00127	CcSEcCtD
Quinine—Skin disorder—Methotrexate—ankylosing spondylitis	0.000187	0.00127	CcSEcCtD
Quinine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000187	0.00126	CcSEcCtD
Quinine—Vomiting—Triamcinolone—ankylosing spondylitis	0.000186	0.00126	CcSEcCtD
Quinine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000185	0.00125	CcSEcCtD
Quinine—Rash—Triamcinolone—ankylosing spondylitis	0.000184	0.00125	CcSEcCtD
Quinine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000184	0.00124	CcSEcCtD
Quinine—Anorexia—Methotrexate—ankylosing spondylitis	0.000184	0.00124	CcSEcCtD
Quinine—Rash—Methylprednisolone—ankylosing spondylitis	0.000184	0.00124	CcSEcCtD
Quinine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000184	0.00124	CcSEcCtD
Quinine—Urticaria—Prednisone—ankylosing spondylitis	0.000183	0.00124	CcSEcCtD
Quinine—Headache—Triamcinolone—ankylosing spondylitis	0.000183	0.00124	CcSEcCtD
Quinine—Headache—Methylprednisolone—ankylosing spondylitis	0.000183	0.00123	CcSEcCtD
Quinine—Abdominal pain—Prednisone—ankylosing spondylitis	0.000183	0.00123	CcSEcCtD
Quinine—Body temperature increased—Prednisone—ankylosing spondylitis	0.000183	0.00123	CcSEcCtD
Quinine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000181	0.00123	CcSEcCtD
Quinine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000181	0.00123	CcSEcCtD
Quinine—Hypotension—Methotrexate—ankylosing spondylitis	0.00018	0.00122	CcSEcCtD
Quinine—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000176	0.00119	CcSEcCtD
Quinine—Dizziness—Betamethasone—ankylosing spondylitis	0.000175	0.00119	CcSEcCtD
Quinine—Dizziness—Dexamethasone—ankylosing spondylitis	0.000175	0.00119	CcSEcCtD
Quinine—Nausea—Triamcinolone—ankylosing spondylitis	0.000174	0.00117	CcSEcCtD
Quinine—Nausea—Methylprednisolone—ankylosing spondylitis	0.000173	0.00117	CcSEcCtD
Quinine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000172	0.00116	CcSEcCtD
Quinine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00017	0.00115	CcSEcCtD
Quinine—Vomiting—Betamethasone—ankylosing spondylitis	0.000169	0.00114	CcSEcCtD
Quinine—Vomiting—Dexamethasone—ankylosing spondylitis	0.000169	0.00114	CcSEcCtD
Quinine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000168	0.00113	CcSEcCtD
Quinine—Rash—Dexamethasone—ankylosing spondylitis	0.000167	0.00113	CcSEcCtD
Quinine—Rash—Betamethasone—ankylosing spondylitis	0.000167	0.00113	CcSEcCtD
Quinine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000167	0.00113	CcSEcCtD
Quinine—Dermatitis—Betamethasone—ankylosing spondylitis	0.000167	0.00113	CcSEcCtD
Quinine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000167	0.00113	CcSEcCtD
Quinine—Headache—Dexamethasone—ankylosing spondylitis	0.000166	0.00112	CcSEcCtD
Quinine—Headache—Betamethasone—ankylosing spondylitis	0.000166	0.00112	CcSEcCtD
Quinine—Asthenia—Prednisone—ankylosing spondylitis	0.000166	0.00112	CcSEcCtD
Quinine—Pruritus—Prednisone—ankylosing spondylitis	0.000163	0.0011	CcSEcCtD
Quinine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000159	0.00108	CcSEcCtD
Quinine—Diarrhoea—Prednisone—ankylosing spondylitis	0.000158	0.00107	CcSEcCtD
Quinine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000158	0.00107	CcSEcCtD
Quinine—Nausea—Dexamethasone—ankylosing spondylitis	0.000157	0.00106	CcSEcCtD
Quinine—Nausea—Betamethasone—ankylosing spondylitis	0.000157	0.00106	CcSEcCtD
Quinine—Urticaria—Methotrexate—ankylosing spondylitis	0.000153	0.00104	CcSEcCtD
Quinine—Dizziness—Prednisone—ankylosing spondylitis	0.000153	0.00103	CcSEcCtD
Quinine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000153	0.00103	CcSEcCtD
Quinine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000153	0.00103	CcSEcCtD
Quinine—Vomiting—Prednisone—ankylosing spondylitis	0.000147	0.000993	CcSEcCtD
Quinine—Rash—Prednisone—ankylosing spondylitis	0.000146	0.000984	CcSEcCtD
Quinine—Dermatitis—Prednisone—ankylosing spondylitis	0.000145	0.000983	CcSEcCtD
Quinine—Headache—Prednisone—ankylosing spondylitis	0.000145	0.000978	CcSEcCtD
Quinine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000142	0.000961	CcSEcCtD
Quinine—Asthenia—Methotrexate—ankylosing spondylitis	0.000138	0.000936	CcSEcCtD
Quinine—Nausea—Prednisone—ankylosing spondylitis	0.000137	0.000927	CcSEcCtD
Quinine—Pruritus—Methotrexate—ankylosing spondylitis	0.000137	0.000923	CcSEcCtD
Quinine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000132	0.000893	CcSEcCtD
Quinine—Dizziness—Methotrexate—ankylosing spondylitis	0.000128	0.000863	CcSEcCtD
Quinine—Vomiting—Methotrexate—ankylosing spondylitis	0.000123	0.00083	CcSEcCtD
Quinine—Rash—Methotrexate—ankylosing spondylitis	0.000122	0.000823	CcSEcCtD
Quinine—Dermatitis—Methotrexate—ankylosing spondylitis	0.000122	0.000822	CcSEcCtD
Quinine—Headache—Methotrexate—ankylosing spondylitis	0.000121	0.000817	CcSEcCtD
Quinine—Nausea—Methotrexate—ankylosing spondylitis	0.000115	0.000775	CcSEcCtD
